Chromatin-modifying proteins in cancer

被引：22

作者：

Fog, Cathrine K. ^{[1
]}

Jensen, Klaus T. ^{[1
]}

Lund, Anders H. ^{[1
]}

机构：

[1] Univ Copenhagen, Ctr Epigenet, Biotech Res & Innovat Ctr, DK-1168 Copenhagen, Denmark

来源：

APMIS | 2007年 / 115卷 / 10期

关键词：

chromatin; epigenetics; cancer; DNA methylation; histone code;

D O I：

10.1111/j.1600-0463.2007.apm_776.xml.x

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Chromatin-modifying proteins mold the genome into areas that are accessible for transcriptional activity and areas that are transcriptionally silent. This epigenetic gene regulation allows for different transcriptional programs to be conducted in different cell types at different timepoints-despite the fact that all cells in the organism contain the same genetic information. A large amount of data gathered over the last decades has demonstrated that deregulation of chromatin-modifying proteins is etiologically involved in the development and progression of cancer. Here we discuss how epigenetic alterations influence cancer development and review known cancer-associated alterations in chromatin-modifying proteins.

引用

页码：1060 / 1089

页数：30

共 50 条

[11] Promoter targeting of chromatin-modifying complexes
Hassan, AH
Neely, KE
Vignali, M
Reese, JC
Workman, JL
FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 : D1054 - D1064
[12] Preparation and Analysis of Native Chromatin-Modifying Complexes
Doyon, Y.
Cote, J.
ENZYMES OF EPIGENETICS, PT A, 2016, 573 : 303 - 318
[13] Assay of activator recruitment of chromatin-modifying complexes
Carrozza, MJ
Hassan, AH
Workman, JL
RNA POLYMERASES AND ASSOCIATED FACTORS, PT D, 2003, 371 : 536 - 544
[14] Characterizing the molecular architectures of chromatin-modifying complexes
Setiaputra, Dheva T.
Yip, Calvin K.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2017, 1865 (11): : 1613 - 1622
[15] Chromatin-Modifying Enzymes in T Cell Development
Shapiro, Michael J.
Shapiro, Virginia Smith
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38, 2020, 38 : 397 - 419
[16] Probing Chromatin-modifying Enzymes with Chemical Tools
Fischle, Wolfgang
Schwarzer, Dirk
ACS CHEMICAL BIOLOGY, 2016, 11 (03) : 689 - 705
[17] Neuronal necrosis is regulated by a conserved chromatin-modifying cascade
Liu, Kai
Ding, Lianggong
Li, Yuhong
Yang, Hui
Zhao, Chunyue
Lei, Ye
Han, Shuting
Tao, Wei
Miao, Dengshun
Steller, Hermann
Welsh, Michael J.
Liu, Lei
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (38) : 13960 - 13965
[18] Chromatin-modifying enzymes as therapeutic targets - Part 1
Keppler, Brian R.
Archer, Trevor K.
EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (10) : 1301 - 1312
[19] Chromatin-modifying drugs and metabolites in cell fate control
Yao, Ziyue
Chen, Yu
Cao, Wenhua
Shyh-Chang, Ng
CELL PROLIFERATION, 2020, 53 (11)
[20] TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins
Pungaliya, Pooja
Kulkarni, Diptee
Park, Hye-Jin
Marshall, Henderson
Zheng, Haiyan
Lackland, Henry
Saleem, Ahamed
Rubin, Eric H.
JOURNAL OF PROTEOME RESEARCH, 2007, 6 (10) : 3918 - 3923

← 1 2 3 4 5 →